Oral Fluvoxamine With Inhaled Budesonide for Treatment of Early-Onset COVID-19: A Randomized Platform Trial – Annals of Internal Medicine Commentary: Combination of fluvoxamine and inhaled budesonide reduces severe COVID-19 in high-risk outpatients – News Medical   Commentary on Twitter Treatment w/ oral fluvoxamine + inhaled budesonide among high-risk outpatients w/ early #COVID19 reduced incidence of […]

The post RCT | Oral fluvoxamine plus inhaled budesonide reduced hospitalizations in high-risk patients with early-onset COVID-19 appeared first on Links Medicus.